Today: 12 May 2026
Nvidia Stock Price Falls 4%: Why Huawei, China Risk and a Nasdaq Correction Matter Now

Nvidia Stock Price Falls 4%: Why Huawei, China Risk and a Nasdaq Correction Matter Now

NEW YORK, March 27, 2026, 08:09 EDT.

Nvidia, after dropping 4.16% to $171.24 on Thursday, faces more pressure as Friday’s session approaches. The chip giant’s market cap is still around $4.53 trillion. U.S. stock index futures remained in the red ahead of the open.

Nvidia now stands in for AI spending across the market, so the latest swing is significant. On Thursday, a wave of selling hit, dragging the Nasdaq down 10.7% from its October 29 peak—a clear correction. Add in a spike in oil prices and traders ditching hopes for Fed rate cuts this year, and the mood turned fast.

Sources told Reuters Huawei’s 950PR chip—designed as a domestic rival to Nvidia—performed well in customer tests, with ByteDance and Alibaba preparing to place orders. Mass production starts next month, and broader shipments are slated for the second half.

The next battleground is inference—the point where AI models actually respond to questions or perform tasks instantly. Nvidia, for its part, projected earlier this month that its AI chip revenue might hit $1 trillion or more through 2027. CEO Jensen Huang, speaking to investors, declared: “the inference inflection has arrived.” Reuters

The race isn’t just in China anymore. Arm told Reuters this week its AGI CPU might hit $15 billion in annual revenue within five years. That sent Arm shares up 20% on Wednesday, while AMD leapt more than 5% as investors wagered that next-gen AI—capable of managing multistep jobs with little human input—will demand more CPUs.

Nvidia’s numbers remain impossible to ignore. Back in February, the chipmaker reported a 73% jump in quarterly revenue to $68.1 billion, with full-year revenue up 65% to $215.9 billion. CEO Jensen Huang described “Enterprise adoption of agents is skyrocketing” and said customers are scrambling to pour money into AI compute. NVIDIA Investor Relations

Yet, analysts keep flagging potential challenges for Nvidia as inference picks up and clients shift toward developing their own chips. “Nvidia is definitely going to see more competition compared to a year ago,” KinNgai Chan at Summit Insights Group said to Reuters this month. Even so, he noted Nvidia continues to command “close to over 90% market share” in both training and inference right now. Reuters

Policy risk could hit first. Reuters reported that four Chinese universities—including a pair with ties to the People’s Liberation Army—have acquired Super Micro servers equipped with restricted Nvidia chips. Two U.S. senators this week pressed Commerce Secretary Howard Lutnick to look into halting export licenses for advanced Nvidia systems destined for China or routed through Southeast Asia. According to Jacob Feldgoise at Georgetown’s Center for Security and Emerging Technology, these transactions might support improvements to China’s weapons design, planning, and autonomous platforms.

There’s also a more immediate issue. According to a Reuters report on Thursday, U.S. utilities and grid operators are now pushing data centers to scale back electricity usage in periods of peak demand. PJM is warning of possible supply gaps as soon as next year. Meanwhile, Nvidia rolled out a partnership with Emerald AI aimed at shifting power draw when the grid is under pressure. So for investors, it comes down to a more basic question: how quickly can all this AI infrastructure translate into actual, running compute?

On Wall Street, the focus has shifted. It’s less about whether AI demand is real—everyone’s on board there—and more about how long Nvidia can keep its edge as AI infrastructure expands. Following February’s numbers, Jacob Bourne at eMarketer told Reuters that ROI questions are heating up for enterprises, especially with hyperscalers now targeting at least $630 billion in capital spending by 2026.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
BMNR stock slides after Bitmine Immersion Technologies launches MAVAN despite B. Riley target hike
Previous Story

BMNR stock slides after Bitmine Immersion Technologies launches MAVAN despite B. Riley target hike

Dow Jones Industrial Average Today: DJIA Falls as Oil Tops $110 and Fed Cut Hopes Fade
Next Story

Dow Jones Industrial Average Today: DJIA Falls as Oil Tops $110 and Fed Cut Hopes Fade

Go toTop